Functional analysis of an essential Trypanosoma brucei protein kinase

布氏锥虫必需蛋白激酶的功能分析

基本信息

  • 批准号:
    9316312
  • 负责人:
  • 金额:
    $ 24.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-01-16 至 2018-12-31
  • 项目状态:
    已结题

项目摘要

Trypanosomatid parasites cause some of the most challenging neglected diseases worldwide. The human- pathogenic triumvirate of Trypanosoma brucei spp., Trypanosoma cruzi, and Leishmania spp. affect hundreds of thousands of individuals, causing human African trypanosomiasis, Chagas’ disease, and a range of visceral to cutaneous lesions, respectively. With no approved vaccines and treatments challenged by resistance, delivery, and efficacy concerns, discovery of new drugs is critical for therapy, control, and elimination of these diseases. Hence, new, validated targets are needed to enter the discovery pipeline. We have recently genetically and chemically validated the T. brucei protein kinase, AEK1, which is both highly conserved in these agents yet different from human protein kinases. The lytic phenotype following knockdown argues that important pathways are controlled by AEK1, yet nothing is known about its regulation or downstream effectors. We propose to fill this knowledge gap. We will test specific cis and trans interactions that we postulate regulate AEK1 activity, including probing a predicted allosteric site and assessing a candidate activating kinase. Our data shows that inhibition of AEK1 leads to inhibition of one or more events required for cytokinesis. To place its action within the cellular context, we will pinpoint the cytologic defect that occurs when AEK1 is inhibited. Because protein kinases exert their functions via modulating downstream effector molecules, the essentiality of AEK1 must reflect essentiality of one or more of its substrates. To identify substrates, we will use a genetically modified AEK1 that specifically accepts large thio-ATP analogs to enable specific thiophosphorylation of its substrates. Substrates will then be captured by virtue of the transferred thiophosphate. Identification of the thiophosphorylated peptides by mass spectrometry will allow development of a list of candidate substrates and a consensus phosphorylation site sequence that will enable identification of additional candidates. The identified molecules will be reviewed for their relationship to the phenotypic processes identified to aid in prioritization for future studies. By revealing mechanisms of regulation and identifying candidate substrates, this project will inform us about the pathway in which AEK1 functions. Given the high similarity of AEK1 across trypanosomatids, it is likely that many of our findings will be applicable to other trypanosomatid pathogens.
锥虫寄生虫导致一些最具挑战性的被忽视的疾病在世界范围内。人类- 布氏锥虫属的致病性三头虫,克氏锥虫(Trypanosoma cruzi)和利什曼原虫(Leishmania spp.)影响数百 成千上万的人,造成人类非洲锥虫病,恰加斯病,和一系列内脏 皮肤病变,分别。由于没有批准的疫苗和治疗方法受到耐药性的挑战, 递送和功效问题,新药的发现对于治疗、控制和消除这些问题至关重要。 疾病因此,需要新的、经过验证的目标来进入发现管道。我们最近 基因和化学验证了T.布氏蛋白激酶AEK 1,它是高度保守的, 这些试剂还不同于人类蛋白激酶。敲低后的裂解表型表明, 重要的通路由AEK 1控制,但对其调节或下游效应物一无所知。 我们希望填补这一知识空白。我们将测试特定的顺式和反式相互作用,我们假设调节 AEK 1活性,包括探测预测的变构位点和评估候选活化激酶。我们 数据显示AEK 1的抑制导致胞质分裂所需的一个或多个事件的抑制。放置 在细胞环境中的作用,我们将查明AEK 1被抑制时发生的细胞学缺陷。 由于蛋白激酶通过调节下游效应分子发挥其功能, AEK 1必须反映一种或多种底物的重要性。为了识别底物,我们将使用遗传学方法, 修饰的AEK 1特异性接受大的硫代ATP类似物,以使其特异性硫代磷酸化 印刷受体.然后,底物将通过转移的硫代磷酸盐被捕获。识别 硫代磷酸化的肽将允许开发候选底物的列表, 能够鉴定其他候选物的共有磷酸化位点序列。的 鉴定的分子将审查其与鉴定的表型过程的关系,以帮助 优先考虑未来的研究。通过揭示调控机制和识别候选底物, 这个项目将告诉我们AEK 1的功能途径。考虑到AEK 1在不同物种之间的高度相似性, 因此,我们的许多发现可能适用于其他锥虫病原体。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Marilyn Parsons其他文献

Marilyn Parsons的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Marilyn Parsons', 18)}}的其他基金

Trypanosome transmembrane kinases
锥虫跨膜激酶
  • 批准号:
    8445189
  • 财政年份:
    2013
  • 资助金额:
    $ 24.5万
  • 项目类别:
Trypanosome transmembrane kinases
锥虫跨膜激酶
  • 批准号:
    8605509
  • 财政年份:
    2013
  • 资助金额:
    $ 24.5万
  • 项目类别:
The Plastid of Toxoplasma gondii
弓形虫质体
  • 批准号:
    8070872
  • 财政年份:
    2010
  • 资助金额:
    $ 24.5万
  • 项目类别:
The Plastid of Toxoplasma gondii
弓形虫质体
  • 批准号:
    7846699
  • 财政年份:
    2009
  • 资助金额:
    $ 24.5万
  • 项目类别:
Mitochondrial Function in Bloodstream Trypanosoma brucei
布氏锥虫血流中的线粒体功能
  • 批准号:
    7617156
  • 财政年份:
    2007
  • 资助金额:
    $ 24.5万
  • 项目类别:
Mitochondrial Function in Bloodstream Trypanosoma brucei
布氏锥虫血流中的线粒体功能
  • 批准号:
    7414452
  • 财政年份:
    2007
  • 资助金额:
    $ 24.5万
  • 项目类别:
Mitochondrial Function in Bloodstream Trypanosoma brucei
布氏锥虫血流中的线粒体功能
  • 批准号:
    7795085
  • 财政年份:
    2007
  • 资助金额:
    $ 24.5万
  • 项目类别:
Mitochondrial Function in Bloodstream Trypanosoma brucei
布氏锥虫血流中的线粒体功能
  • 批准号:
    8064395
  • 财政年份:
    2007
  • 资助金额:
    $ 24.5万
  • 项目类别:
The Plastid of Toxoplasma gondii
弓形虫质体
  • 批准号:
    7622173
  • 财政年份:
    2002
  • 资助金额:
    $ 24.5万
  • 项目类别:
The Plastid of Toxoplasma gondii
弓形虫质体
  • 批准号:
    7555004
  • 财政年份:
    2002
  • 资助金额:
    $ 24.5万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 24.5万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.5万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 24.5万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 24.5万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 24.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 24.5万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 24.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了